Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 29

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 29
---
 same for all issued and outstanding
shares of Common Stock. The Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder’s
percentage ownership interests in our company, except those stockholders who would have otherwise received fractional shares will receive
cash in lieu of such fractional shares determined in the manner set forth below under the heading “Fractional Shares.” After
the Reverse Stock Split, each share of the Common Stock will have the same voting rights and rights to dividends and distributions and
will be identical in all other respects to the Common Stock now authorized. The Reverse Stock Split will not affect us continuing to be
subject to the periodic reporting requirements of the Exchange Act. The Reverse Stock Split is not intended to be, and will not have the
effect of, a “going private transaction” covered by Rule 13e-3 under the Exchange Act.

The Reverse Stock Split may result in some stockholders
owning “odd-lots” of less than 100 shares of the Common Stock. Brokerage commissions and other costs of transactions in odd-lots
are generally higher than the costs of transactions in “round-lots” of even multiples of 100 shares. In addition, we will
not issue fractional shares in connection with the Reverse Stock Split, and stockholders who would have otherwise been entitled to receive
such fractional shares will receive an amount in cash determined in the manner set forth below under the heading “Fractional Shares.”

Following the effectiveness of the Reverse Stock Split,
if approved by the stockholders and implemented by the Company, current stockholders will hold fewer shares of Common Stock.

If the Board decides to implement the Reverse Stock
Split, the Company would communicate to the public, prior to the effective time of the Reverse Stock Split, additional details regarding
the Reverse Stock Split (including the final Reverse Stock Split Ratio, as determined by the Board of Directors). By voting in favor of
the Reverse Stock Split, you are also expressly authorizing the Board to determine not to proceed with, and to defer or to abandon, the
Reverse Stock Split, in the Board of Director’s sole discretion. In determining whether to implement the Reverse Stock Split following
receipt of stockholder approval of the Reverse Stock Split, and which Reverse Stock Split Ratio to implement, if any, the Board may consider,
among other things, various factors, such as:

| ● | our ability to maintain our listing on the Nasdaq Capital Market;                                                                                                                                  |
| ● | the historical trading price and trading volume of the